blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2277538

EP2277538 - Combined meningitis vaccines [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.01.2020
Database last updated on 03.09.2024
FormerExamination is in progress
Status updated on  06.03.2019
Most recent event   Tooltip24.01.2020Application deemed to be withdrawnpublished on 26.02.2020  [2020/09]
Applicant(s)For all designated states
GlaxoSmithKline Biologicals s.a.
rue de l'Institut 89
1330 Rixensart / BE
[2017/37]
Former [2011/27]For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
Former [2011/04]For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena (SI) / IT
Inventor(s)01 / Contorni, Mario
c/o Novartis Vaccines Via Fiorentina 1
53100 Siena / IT
 [2011/04]
Representative(s)Dalton, Marcus Jonathan William, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2011/04]Marshall, Cameron John
Carpmaels & Ransford One Southampton Row London
WC1B 5HA / GB
Application number, filing date10180408.604.10.2004
[2011/04]
Priority number, dateGB2003002310202.10.2003         Original published format: GB 0323102
GB2004001205228.05.2004         Original published format: GB 0412052
[2011/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2277538
Date:26.01.2011
Language:EN
[2011/04]
Search report(s)(Supplementary) European search report - dispatched on:EP17.12.2010
ClassificationIPC:A61K39/095, A61K39/102, A61K39/09
[2011/04]
CPC:
A61K39/095 (EP,US); A61K9/19 (US); A61K39/102 (EP,US);
A61K39/39 (EP,US); A61K47/646 (EP,US); A61P25/00 (EP);
A61P31/04 (EP); A61P31/12 (EP); A61P37/04 (EP);
A61K2039/55505 (EP,US); A61K2039/6037 (EP,US); A61K2039/6068 (EP,US);
A61K2039/70 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/04]
TitleGerman:Kombinationsimpfstoffe gegen Meningitis[2011/04]
English:Combined meningitis vaccines[2011/04]
French:Vaccins combinés contre la méningite[2011/04]
Examination procedure26.07.2011Examination requested  [2011/35]
11.11.2011Amendment by applicant (claims and/or description)
23.05.2012Despatch of a communication from the examining division (Time limit: M06)
19.03.2013Reply to a communication from the examining division
09.04.2014Despatch of a communication from the examining division (Time limit: M11)
24.06.2015Reply to a communication from the examining division
11.03.2019Despatch of a communication from the examining division (Time limit: M06)
24.09.2019Application deemed to be withdrawn, date of legal effect  [2020/09]
18.10.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2020/09]
Parent application(s)   TooltipEP04791703.4  / EP1670506
EP08075538.2  / EP1961426
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040791703) is  13.06.2007
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
24.06.2015Request for further processing filed
24.06.2015Full payment received (date of receipt of payment)
Request granted
17.07.2015Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
19.03.2013Request for further processing filed
19.03.2013Full payment received (date of receipt of payment)
Request granted
04.04.2013Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
11.11.2011Request for further processing filed
11.11.2011Full payment received (date of receipt of payment)
Request granted
25.11.2011Decision despatched
Fees paidRenewal fee
27.09.2010Renewal fee patent year 03
27.09.2010Renewal fee patent year 04
27.09.2010Renewal fee patent year 05
27.09.2010Renewal fee patent year 06
27.09.2010Renewal fee patent year 07
11.10.2011Renewal fee patent year 08
11.10.2012Renewal fee patent year 09
14.10.2013Renewal fee patent year 10
14.10.2014Renewal fee patent year 11
07.10.2015Renewal fee patent year 12
07.10.2016Renewal fee patent year 13
10.10.2017Renewal fee patent year 14
05.10.2018Renewal fee patent year 15
08.10.2019Renewal fee patent year 16
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0200249  (SMITHKLINE BEECHAM BIOLOG [BE], et al) [X] 1-15 * page 7, line 14 - page 8, line 33; examples 2,3 *;
 [XP]WO2004067030  (CHIRON SRL [IT], et al) [XP] 1-15 * page 1, line 30 - page 2, line 21 * * page 10, line 35 - page 11, line 19 * * page 27, line 14 - line 29 ** page 34, line 15 - line 18 *;
 [A]  - CRIPPS A W ET AL, "Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis", CURRENT OPINION IN IMMUNOLOGY, CURRENT BIOLOGY LTD, (20021001), vol. 14, no. 5, ISSN 0952-7915, pages 553 - 557, XP004377406 [A] 1-15 * page 554, column R, paragraph 2 - page 555, column L, paragraph 1 * * page 555, column L, paragraph 3 * * page 555, column L, paragraph L - column R, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0952-7915(02)00373-4
 [A]  - PELTOLA H, "Prophylaxis of bacterial meningitis.", INFECTIOUS DISEASE CLINICS OF NORTH AMERICA SEP 1999, (199909), vol. 13, no. 3, ISSN 0891-5520, pages 685 - 710 , vii, XP000999602 [A] 1-15 * page 689, paragraph 4 - page 693, paragraph 5 * * page 701, paragraph 2 - page 702, paragraph 1 * * page 704, paragraph 3 - paragraph 4 *

DOI:   http://dx.doi.org/10.1016/S0891-5520(05)70101-X
ExaminationWO2004032958
by applicantUS4057685
 US4356170
 EP0109942
 US4459286
 EP0208375
 US4663160
 US4673574
 US4695624
 US4761283
 US4808700
 US4882317
 EP0372501
 EP0378881
 US4965338
 WO9014837
 WO9101146
 EP0427347
 US5057540
 EP0471177
 WO9203467
 EP0477508
 WO9306861
 WO9317712
 WO9324148
 WO9400153
 WO9403208
 EP0586266
 WO9405325
 US5306492
 EP0594610
 EP0626169
 WO9508348
 US5425946
 WO9517211
 EP0689454
 WO9611711
 WO9614086
 EP0735898
 WO9633739
 WO9637222
 WO9640242
 WO9700697
 EP0761231
 EP0835318
 WO9840100
 WO9842721
 WO9842375
 WO9857659
 WO9858668
 WO9911241
 WO9924578
 WO9927960
 US5912336
 WO9931132
 US5916588
 WO9936544
 WO9940936
 WO9942130
 WO9944636
 WO9952549
 WO9957280
 WO9958683
 WO9962923
 WO0007621
 WO0010599
 WO0022430
 WO0038711
 US6090406
 WO0056360
 WO0056365
 WO0061761
 WO0066741
 US6146902
 US6207646
 WO0121207
 WO0121152
 WO0130390
 US6239116
 WO0164920
 WO0164922
 WO0172337
 WO0195935
 US6333036
 WO0200249
 WO0222167
 WO0226757
 WO02058737
 US6429199
 WO02091998
 US6495345
 WO03007985
 WO03010194
 WO03009869
 WO03020756
 WO03024480
 WO03024481
 WO03035836
 WO03063766
 WO03080678
 WO2004014419
 WO2004015099
 WO2004014418
 WO2004032958
 WO2004048404
 WO2004083251
 WO2005033148
    - DARKES; PLOSKER, PAEDIATR DRUGS, (2002), vol. 4, pages 609 - 630
    - JONES, CURR OPIN INVESTIG DRUGS, (2001), vol. 2, pages 47 - 49
    - ARMAND ET AL., J. BIOL. STAND., (1982), vol. 10, pages 335 - 339
    - CADOZ ET AL., VACCINE, (1985), vol. 3, pages 340 - 342
    - BAKLAIC ET AL., INFECT. IMMUN., (1983), vol. 42, pages 599 - 604
    - MMWR, (1997), vol. 46, no. RR-5, pages 1 - 10
    - BJUNE ET AL., LANCET, (1991), vol. 338, no. 8775, pages 1093 - 96
    - FRASH, Advances in Biotechnological Processes, (1990), vol. 13, pages 123 - 145
    - INZANA, INFECT. IMMUN., (1987), vol. 55, pages 1573 - 1579
    - KANDIL ET AL., GLYCOCONJ J, (1997), vol. 14, pages 13 - 17
    - BERKIN ET AL., CHEMISTRY, (2002), vol. 8, pages 4424 - 4433
    - GLODE ET AL., J INFECT DIS, (1979), vol. 139, pages 52 - 56
    - NILSSON; SVENSSON, CARBOHYDRATE RESEARCH, (1979), vol. 69, pages 292 - 296
    - RAMSAY ET AL., LANCET, (2001), vol. 357, no. 9251, pages 195 - 196
    - LINDBERG, VACCINE, (1999), vol. 17, no. 2, pages S28 - 36
    - BUTTERY; MOXON, JR COLL PHYSICIANS LOND, (2000), vol. 34, pages 163 - 168
    - AHMAD; CHAPNICK, INFECT DIS CLIN NORTH AM, (1999), vol. 13, pages 113 - 133
    - GOLDBLATT, J. MED. MICROBIOL., (1998), vol. 47, pages 563 - 567
    - Conjugate Vaccines, vol. 10, pages 48 - 114
    - ANONYMOUS, RESEARCH DISCLOSURE, (200201), page 453077
    - ANDERSON, INFECT IMMUN, (1983), vol. 39, no. 1, pages 233 - 238
    - ANDERSON ET AL., J CLIN INVEST, (1985), vol. 76, no. 1, pages 52 - 59
    - FALUGI ET AL., EUR J IMMUNOL, (2001), vol. 31, pages 3816 - 3824
    - BARALDO ET AL., INFECT IMMUN., (2004), vol. 72, pages 4884 - 7
    - KUO ET AL., INFECT IMMUN, (1995), vol. 63, pages 2706 - 13
    - LEES ET AL., VACCINE, (1996), vol. 14, pages 190 - 198
    - PORRO ET AL., MOL IMMUNOL, (1985), vol. 22, pages 907 - 919
    - GEVER ET AL., MED. MICROBIOL. IMMUNOL, (1979), vol. 165, pages 171 - 288
    - LEI ET AL., DEV BIOL (BASEL), (2000), vol. 103, pages 259 - 264
    - LAMB ET AL., DEV BIOL (BASEL), (2000), vol. 103, pages 251 - 258
    - LAMB ET AL., JOURNAL OF CHROMOTOGRAPHY A, (2000), vol. 894, pages 311 - 318
    - D'AMBRA ET AL., DEV BIOL (BASEL), (2000), vol. 103, pages 241 - 242
    - RAVENSCROFT ET AL., VACCINE, (1999), vol. 17, pages 2802 - 2816
    - COSTANTINO ET AL., VACCINE, (1999), vol. 17, pages 1251 - 1263
    - PARKHILL ET AL., NATURE, (2000), vol. 404, pages 502 - 506
    - TETTELIN ET AL., SCIENCE, (2000), vol. 287, pages 1809 - 1815
    - PIZZA ET AL., SCIENCE, (2000), vol. 287, pages 1816 - 1820
    - PEAK ET AL., FEMS IMMUNOL MED MICROBIOL, (2000), vol. 28, pages 329 - 334
    - COMANDUCCI ET AL., J. EXP. MED., (2002), vol. 195, pages 1445 - 1454
    - MASIGNANI ET AL., JEXP MED, (2003), vol. 197, pages 789 - 799
    - PETTERSSON ET AL., MICROB PATHOG, (1994), vol. 17, no. 6, pages 395 - 408
    - MAIDEN ET AL., PNAS USA, (1998), vol. 95, pages 3140 - 3145
    - GUSTAFSSON ET AL., N. ENGL. J. MED., (1996), vol. 334, pages 349 - 355
    - RAPPUOLI ET AL., TIBTECH, (1991), vol. 9, pages 232 - 238
    - BELL, PEDIATR INFECT DIS J, (2000), vol. 19, pages 1187 - 1188
    - IWARSON, APMIS, (1995), vol. 103, pages 321 - 326
    - GERLICH ET AL., VACCINE, (1990), vol. 8, pages S63 - 68,79-80
    - SUTTER ET AL., PEDIATR CLIN NORTH AM, (2000), vol. 47, pages 287 - 308
    - ZIMMERMAN; SPANN, AM FAM PHYSICIAN, (1999), vol. 59, pages 113 - 118,125-126
    - CHARALAMBOUS; FEAVERS, JMED MICROBIOL, (2001), vol. 50, pages 937 - 939
    - WESTERINK, INT REV IMMUNOL, (2001), vol. 20, pages 251 - 261
    - GROTHAUS ET AL., VACCINE, (2000), vol. 18, pages 1253 - 1263
    - KANRA ET AL., THE TURKISH JOURNAL OF PAEDIATRICS, (1999), vol. 42, pages 421 - 427
    - RAVENSCROFT ET AL., DEV BIOL (BASEL), (2000), vol. 103, pages 35 - 47
    - WATSON, PEDIATR INFECT DIS J, (2000), vol. 19, pages 331 - 332
    - RUBIN, PEDIATR CLIN NORTH AM, (2000), vol. 47, pages 269 - 285
    - JEDRZEJAS, MICROBIOL MOL BIOL REV, (2001), vol. 65, pages 187 - 207
    - ZIELEN ET AL., INFECT. IMMUN., (2000), vol. 68, pages 1435 - 1440
    - TETTELIN ET AL., SCIENCE, (2001), vol. 293, pages 498 - 506
    - HOSKINS ET AL., JBACTERIOL, (2001), vol. 183, pages 5709 - 5717
    - RAPPUOLI, CURR OPIN MICROBIOL, (2000), vol. 3, pages 445 - 450
    - RAPPUOLI, VACCINE, (2001), vol. 19, pages 2688 - 2691
    - MASIGNANI ET AL., EXPERT OPIN BIOL THER, (2002), vol. 2, pages 895 - 905
    - MORA ET AL., DRUG DISCOV TODAY, (2003), vol. 8, pages 459 - 464
    - WIZEMANN ET AL., INFECT IMMUN, (2001), vol. 69, pages 1593 - 1598
    - RIGDEN ET AL., CRIT REV BIOCHEM MOL BIOL, (2003), vol. 38, pages 143 - 168
    - PAOLETTI ET AL., VACCINE, (2001), vol. 19, pages 2118 - 2126
    - BARR ET AL., ADVANCED DRUG DELIVERY REVIEWS, (1998), vol. 32, pages 247 - 271
    - SJOLANDERET ET AL., ADVANCED DRUG DELIVERY REVIEWS, (1998), vol. 32, pages 321 - 338
    - NIIKURA ET AL., VIROLOGY, (2002), vol. 293, pages 273 - 280
    - LENZ ET AL., J IMMUNOL, (2001), vol. 166, pages 5346 - 5355
    - PINTO ET AL., J INFECT DIS, (2003), vol. 188, pages 327 - 338
    - GERBER ET AL., VIROL, (2001), vol. 75, pages 4752 - 4760
    - GLUCK ET AL., VACCINE, (2002), vol. 20, pages B10 - B16
    - JOHNSON ET AL., BIOORG MED CHEM LETT, (1999), vol. 9, pages 2273 - 2278
    - EVANS ET AL., EXPERT REV VACCINES, (2003), vol. 2, pages 219 - 229
    - MERALDI ET AL., VACCINE, (2003), vol. 21, pages 2485 - 2491
    - PAJAK ET AL., VACCINE, (2003), vol. 21, pages 836 - 842
    - KANDIMALLA ET AL., NUCLEIC ACIDS RESEARCH, (2003), vol. 31, pages 2393 - 2400
    - KRIEG, NATURE MEDICINE, (2003), vol. 9, pages 831 - 835
    - MCCLUSKIE ET AL., FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, (2002), vol. 32, pages 179 - 185
    - KANDIMALLA ET AL., BIOCHEMICAL SOCIETY TRANSACTIONS, (2003), vol. 31, pages 654 - 658
    - BLACKWELL ET AL., J IMMUNOL, (2003), vol. 170, pages 4061 - 4068
    - KRIEG, TRENDS IMMUNOL, (2002), vol. 23, pages 64 - 65
    - KANDIMALLA ET AL., BBRC, (2003), vol. 306, pages 948 - 953
    - BHAGAT ET AL., BBRC, (2003), vol. 300, pages 853 - 861
    - BEIGNON ET AL., INFECT IMMUN, (2002), vol. 70, pages 3012 - 3019
    - PIZZA ET AL., VACCINE, (2001), vol. 19, pages 2534 - 2541
    - PIZZA ET AL., INT J MED MICROBIOL, (2000), vol. 290, pages 455 - 461
    - SCHARTON-KERSTEN ET AL., INFECT IMMUN, (2000), vol. 68, pages 5306 - 5313
    - RYAN ET AL., INFECT IMMUN, (1999), vol. 67, pages 6270 - 6280
    - PARTIDOS ET AL., IMMUNOL LETT, (1999), vol. 67, pages 209 - 216
    - PEPPOLONI ET AL., EXPERT REV VACCINES, (2003), vol. 2, pages 285 - 293
    - PINE ET AL., J CONTROL RELEASE, (2002), vol. 85, pages 263 - 270
    - DOMENIGHINI ET AL., MOL MICROBIOL, (1995), vol. 15, pages 1165 - 1167
    - SINGH ET AL., J CONT RELEASE, (2001), vol. 70, pages 267 - 276
    - ANDRIANOV ET AL., BIOMATERIALS, (1998), vol. 19, pages 109 - 115
    - PAYNE ET AL., ADV DRUG DELIVERY REVIEW, (1998), vol. 31, pages 185 - 196
    - STANLEY, CLIN EXP DERMATOL, (2002), vol. 27, pages 571 - 577
    - JONES, CURR OPIN INVESTIG DRUGS, (2003), vol. 4, pages 214 - 218
    - ALMEIDA; ALPAR, J. DRUG TARGETING, (1996), vol. 3, pages 455 - 467
    - AGARWAL; MISHRA, INDIAN J EXP BIOL, (1999), vol. 37, pages 6 - 16
    - JAKOBSEN ET AL., INFECT IMMUN, (2002), vol. 70, pages 1443 - 1452
    - WU ET AL., J INFECT DIS, (1997), vol. 175, pages 839 - 846
    - BERGQUIST ET AL., APMIS, (1998), vol. 106, pages 800 - 806
    - BAUDNER ET AL., INFECT IMMUN, (2002), vol. 70, pages 4785 - 4790
    - UGOZZOLI ET AL., JLNFECT DIS, (2002), vol. 186, pages 1358 - 1361
    - SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, pages 482 - 489
 GB20020023741
 GB20030005831
 GB20030009115
 GB20040008978
 GB20040008977
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.